Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GarlicRich in pediatric alopecia areata
NCT02691117Phase 3Terminated
- Start
- Jan 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of GarlicRich in alopecia areata. Primary endpoint: Percentage change of SALT scores at 6 months. Started Jan 2016; status: terminated.
02
Drugs
GarlicRich
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT02691117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02691117.